“`html
The Invesco Russell 1000 Equal Weight ETF (Symbol: EQAL) has an implied analyst target price of $57.94 per unit, indicating an 11.45% upside from its recent trading price of $51.99. This data is based on a comparison of the ETF’s underlying holdings against the average analyst 12-month forward target prices, as of the latest analysis.
Key underlying holdings contributing to this outlook include Revolution Medicines Inc (RVMD), with an expected target price of $74.06, representing an 82.87% upside from its recent price of $40.50; Ingram Micro Holding Corp (INGM), with a target of $25.33, or 26.54% above its current price of $20.02; and Ashland Inc (ASH), with a target of $67.50, signifying a 22.93% increase from its recent trading price of $54.91.
“`
